New FDA Webinar Series on Substantial Equivalence Predicate Preview Process

The U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) has received questions about how companies can improve the quality of their premarket applications under the substantial equivalence (SE) pathway. To help, FDA is launching a three-part webinar series on the SE predicate review process.